HEXO Announces 1-For-14 Share Reverse Stock Split

HEXO Corp. (TSX:HEXO, NASDAQ:HEXO) ("HEXO" or the "Company"), a leading producer of high-quality cannabis products, today announced that, following shareholder approval of a consolidation of the

HEXO Corp. (TSX:HEXO, NASDAQ:HEXO) (“HEXO” or the “Company“), a leading producer of high-quality cannabis products, today announced that, following shareholder approval of a consolidation of the common shares of the Company (“Common ‎Shares“) on the basis of a range between two (2) and fourteen (14) existing pre-consolidation Common ‎Shares for every one (1) post-consolidation Common Share (the “Consolidation“) at the annual and special meeting of the shareholders of the Company held on March 8, 2022, it has filed articles of amendment implementing the Consolidation on the basis of fourteen (14) existing pre-consolidation Common ‎Shares for every one (1) post-consolidation Common Share.

Total
0
Shares
Related Posts
Read More

Ligand Pharmaceuticals Sees 2023 Total Core Revenue Of $118M-$122M; Sees Adjusted Diluted EPS Of $3.10-$3.30 In 2023; Ligand Estimates That At End Of 2022 It Will Have $150M Of Cash And Investments Available To Fund Its M&A Initiatives

Executive Management Reviewed Business Model and Growth Drivers Following the Successful Spin-Off of OmniAb, Introduced 2023 Financial Guidance Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) announced that

LGND